Potential of mirabegron and its extended-release formulations for the treatment of overactive bladder syndrome.
Conclusion: Mirabegron shows a distinct mode of action, i.e., targeting β3-adrenoreceptors and improve bladder storage without altering void contractions. The limited side effects, high safety, efficacy and tolerability of mirabegron present an adequate substitute to antimuscarinics. However, long-term analysis and clinical studies are prerequisites for assessing the safety , tolerebility and efficacy profile of mirabegron.
PMID: 32334500 [PubMed - as supplied by publisher]
Source: Current Drug Metabolism - Category: Drugs & Pharmacology Authors: Mandpe P, Prabhakar B, Shende P Tags: Curr Drug Metab Source Type: research
More News: Chloride | Clinical Trials | Constipation | Detrol | Drugs & Pharmacology | Overactive Bladder | Overactive Bladder Syndrome | Study | Toxicology | Urology & Nephrology | VESIcare